Tag: USA NAM NOR SCA EUR

Hemispherian receives positive opinion for Orphan Medicinal Product Designation in the EU for GLIX1 in glioma

OSLO, Norway, June 6, 2025 /PRNewswire/ -- Hemispherian AS, a pioneering biotech company developing next-generation therapeutics for aggressive cancers, announced today that the European...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsUSA NAM NOR SCA EUR

FGR accelerates USA expansion & defence sector exposure with strategic acquisition of MITO® Material Solutions

Liftoff Announces Pricing of Initial Public Offering

Quantinuum Announces Pricing of Upsized Initial Public Offering

Tag: USA NAM NOR SCA EUR

Hemispherian receives positive opinion for Orphan Medicinal Product Designation in the EU for GLIX1 in glioma

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us